Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists.
Maas AHEM, Rosano G, Cifkova R, Chieffo A, van Dijken D, Hamoda H, Kunadian V, Laan E, Lambrinoudaki I, Maclaran K, Panay N, Stevenson JC, van Trotsenburg M, Collins P. Maas AHEM, et al. Among authors: hamoda h. Eur Heart J. 2021 Mar 7;42(10):967-984. doi: 10.1093/eurheartj/ehaa1044. Eur Heart J. 2021. PMID: 33495787 Free PMC article.
A randomised controlled trial comparing the effects of micronized progesterone to medroxyprogesterone acetate on cardiovascular health, lipid metabolism and the coagulation cascade in women with premature ovarian insufficiency: study protocol and review of the literature.
Mittal M, Savvas M, Arya R, McEniery C, Narvekar N, Cardozo L, Panay N, Hamoda H. Mittal M, et al. Among authors: hamoda h. Menopause Int. 2013 Sep;19(3):127-32. doi: 10.1177/1754045313503635. Menopause Int. 2013. PMID: 24072634 Clinical Trial.
A direct comparison of women's perceptions and acceptability of micronised progesterone and medroxyprogesterone acetate in combination with transdermal oestradiol in the management of young postmenopausal women, under 45 years of age.
Mittal M, Panay N, Supramaniam PR, Savvas M, Cardozo L, Hamoda H. Mittal M, et al. Among authors: hamoda h. Post Reprod Health. 2020 Dec;26(4):210-219. doi: 10.1177/2053369120960960. Epub 2020 Oct 12. Post Reprod Health. 2020. PMID: 33045913 Clinical Trial.
Cardiometabolic health in premature ovarian insufficiency.
Stevenson JC, Collins P, Hamoda H, Lambrinoudaki I, Maas AHEM, Maclaran K, Panay N. Stevenson JC, et al. Among authors: hamoda h. Climacteric. 2021 Oct;24(5):474-480. doi: 10.1080/13697137.2021.1910232. Epub 2021 Jun 25. Climacteric. 2021. PMID: 34169795 Review.
The essential menopause curriculum for healthcare professionals: A European Menopause and Andropause Society (EMAS) position statement.
Rees M, Abernethy K, Bachmann G, Bretz S, Ceausu I, Durmusoglu F, Erkkola R, Fistonic I, Gambacciani M, Geukes M, Goulis DG, Griffiths A, Hamoda H, Hardy C, Hartley C, Hirschberg AL, Kydd A, Marshall S, Meczekalski B, Mendoza N, Mueck A, Persand E, Riach K, Smetnik A, Stute P, van Trotsenburg M, Yuksel N, Weiss R, Lambrinoudaki I. Rees M, et al. Among authors: hamoda h. Maturitas. 2022 Apr;158:70-77. doi: 10.1016/j.maturitas.2021.12.001. Epub 2022 Feb 1. Maturitas. 2022. PMID: 35115178 Review.
107 results